Novartis Faces Lawsuit Over Alleged 'Sham' Gilenya Promotions Novartis is accused of organizing 'sham' events to promote Gilenya, resulting in fraudulent claims to government health insurance programs. Discover the details.
Company Faces Financial Crisis Amid SEC Fraud Fine The company is on the brink of financial collapse with cash reserves dwindling by 2024 and a hefty $25 million SEC fine for fraud allegations. Learn more.